Abstract
The infusion of lymphocytes from the original donor (DLI) to a recipient of an allogeneic stem cell transplantation (SCT) has been the case of cellular immunotherapy. Following its introduction in the late 1980's, unmodified donor cells have been used within the treatment of post-transplant relapse in various hematological malignancies. Later
... read more